NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $440,443 | -39.2% | 4,324 | -39.8% | 0.01% | -38.1% |
Q2 2023 | $724,837 | +72.2% | 7,183 | +57.0% | 0.02% | +50.0% |
Q1 2023 | $420,900 | -10.5% | 4,575 | -11.7% | 0.01% | -12.5% |
Q4 2022 | $470,112 | +12.2% | 5,182 | -6.1% | 0.02% | -5.9% |
Q3 2022 | $419,000 | -16.9% | 5,520 | -7.5% | 0.02% | -15.0% |
Q2 2022 | $504,000 | +10.3% | 5,967 | +14.6% | 0.02% | +5.3% |
Q1 2022 | $457,000 | +38.5% | 5,207 | +37.9% | 0.02% | +35.7% |
Q4 2021 | $330,000 | +19.6% | 3,775 | +12.0% | 0.01% | +7.7% |
Q3 2021 | $276,000 | +18.5% | 3,371 | +32.0% | 0.01% | +18.2% |
Q2 2021 | $233,000 | -24.8% | 2,553 | -29.7% | 0.01% | -26.7% |
Q1 2021 | $310,000 | -10.1% | 3,631 | -0.5% | 0.02% | -11.8% |
Q4 2020 | $345,000 | +50.7% | 3,650 | +38.5% | 0.02% | +30.8% |
Q3 2020 | $229,000 | -2.6% | 2,636 | -1.9% | 0.01% | -13.3% |
Q2 2020 | $235,000 | +14.1% | 2,686 | +7.4% | 0.02% | -11.8% |
Q1 2020 | $206,000 | – | 2,502 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |